JCI
Johnson Controls International plc
JCI has lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over JCI overall, supported by stronger valuation and stronger modeled upside.
JCI Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Strong | |
| Stable |
JCI's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
JCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 20x | $95.28 | -33% |
| Forward | 22x | $143 | — |
| Fair | 30x | $139 | -2.7% |
| Current | 31x | $143 | — |
| Expensive | 36x | $169 | +18% |
Historical ranges are pointers, not guarantees.
JCI's PE is in its fair range at 31x. If earnings grow as analysts expect, today's price would be 22x next year's earnings, in its cheap range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over JCI in the historical PE scenario, which offers more potential upside but is not a forecast.
JCI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| High |
Analysts expect earnings and revenue growth for JCI, with profitability improving.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
JCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.34 | +36% |
| Q3 2026 | $4.67 | -7.2% |
| Q2 2026 | $5.68 | +70% |
| Q1 2026 | $5.53 | +48% |
| Q4 2025 | $5.25 | +102% |
| Q3 2025 | $5.03 | +100% |
| Q2 2025 | $3.35 | +40% |
| Q1 2025 | $3.73 | +51% |
| Q4 2024 | $2.60 | -15% |
JCI's earnings per share have fallen from their peak: $4.67 over the past year, against $6.32 in late 2019.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over JCI on earnings, with more consistent year-over-year improvement.
JCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $7.1B | +10% |
| Q2 2026 | $6.6B | +9.3% |
| Q1 2026 | $6.1B | +8.2% |
| Q4 2025 | $5.8B | +6.8% |
| Q3 2025 | $6.4B | +120% |
| Q2 2025 | $6.1B | -16% |
| Q1 2025 | $5.7B | -15% |
| Q4 2024 | $5.4B | -11% |
JCI's revenue has grown year over year for five quarters in a row: $7.1B last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | +9.4 points |
| Q2 2026 | 15% | +3.3 points |
| Q1 2026 | 12% | +3.2 points |
| Q4 2025 | 12% | +4.7 points |
| Q3 2025 | 5.5% | -1.4 points |
| Q2 2025 | 12% | -6 points |
| Q1 2025 | 8.8% | +14 points |
| Q4 2024 | 7.5% | +0.9 points |
JCI's operating margin was 15% last quarter, up 9.4 points from the same quarter a year ago, near the top of its range since 2019.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over JCI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over JCI on profitability, with a higher operating margin.
JCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +29% |
| Q2 2026 | $1.5B | +117% |
| Q1 2026 | $604M | +32% |
| Q4 2025 | $531M | +299% |
| Q3 2025 | $838M | +1.5% |
| Q2 2025 | $693M | -25% |
| Q1 2025 | $456M | +$792M |
| Q4 2024 | $133M | +$471M |
JCI generated $3.7B in free cash flow over the past year, up 75% from the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT generated $3.1B in free cash flow over the past year, up 127% from the year before.
JCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -2M shares |
| 1 year | -6.6% | -43.1M shares |
| 3 years | -11% | -76.4M shares |
| 5 years | -15% | -110M shares |
| Available history | -21% | -163M shares |
JCI has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $655M |
| Q2 2026 | $264M |
| Q1 2026 | $215M |
| Q4 2025 | — |
| Q3 2025 | $5B |
| Q2 2025 | $310M |
| Q1 2025 | $330M |
| Q4 2024 | $330M |
JCI spent $1.1B buying back its own shares over the past year, down 81% from the year before.
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
JCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.1x | Moderate |
| Q2 2026 | 2.5x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 3.0x | Moderate |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 3.8x | Elevated |
| Q1 2025 | 2.9x | Moderate |
| Q4 2024 | 3.8x | Elevated |
JCI's net debt is about 2.1 years of its operating earnings (EBITDA), down from 3.4 years a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over JCI on leverage, with a lower net debt burden relative to earnings.
JCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.6 | Neutral |
| Stochastic | 35.5 | Neutral |
JCI's weekly RSI is 50 (neutral) and its Stochastic is 35 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
JCI PE vs Industrials Sector
| Metric | JCI | Sector median | Relative |
|---|---|---|---|
| PE | 31x | 24x | 27% above |
| PE % | 56 | 58 | 2 pts below |
JCI has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
JCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $147.5 | 3.3% below |
| 20 week MA | $145.8 | 2.2% below |
| 50 week MA | $137.7 | 3.5% above |
| 100 week MA | $117.3 | 22% above |
| 200 week MA | $90.8 | 57% above |
JCI has the edge over VRT on trend strength, trading above more of its moving averages.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
JCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.1 | $45.9 | +12% |
| 2021 | $45.9 | $78.1 | +70% |
| 2022 | $78.1 | $64.1 | -18% |
| 2023 | $64.1 | $57.6 | -10% |
| 2024 | $57.6 | $79.8 | +38% |
| 2025 | $79.8 | $122.1 | +53% |
| 2026 YTD | $122.1 | $142.6 | +17% |
JCI has finished higher in four of the last six years, two of them by more than 50%. It's up 17% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over JCI on returns for 2026, with the stronger performance.